SAM Chun Dang Pharm

삼천당제약KRX: 000250· Fiscal year 2025· scd.co.kr ↗

Average salary
$49.4K
₩65.8M
▼ 0.9% vs 2024
Employees
436
▲ 4.6% vs 2024
Average tenure
8.3 yrs

Estimated take-home of this pay:$3.4K / monthCalculate →

Workplace

Women's pay (men = 100)67
Women among staff29.8%
Contract staff2.3%

Recent official filings

Quick read

  • Average pay is 8% above the median of the companies we track.
  • Average pay fell 0.9% from 2024.
  • Headcount grew by 19 (4.6%) from 2024.
  • Ranks #67 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 9.9% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 3.7% in 2025.

Last 3 years

Revenue
$144.6M2023$158.3M2024$174.0M2025
Operating income
$7.2M2023$2.0M2024$6.4M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$398.1K
Net profit per employee
$20.7K
Operating margin
3.7%
Net margin
5.2%
ROE
3.3%
Debt-to-equity
54.4%
Equity ratio
64.8%
Payout ratio
22.1%
Dividend per share
$0
Dividend yield (as disclosed)
0.0%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.